Advertisement Covance signs drug development services agreement with Lilly - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Covance signs drug development services agreement with Lilly

Covance, a provider of drug development services, has closed its transaction with Eli Lilly and Company to provide a broad-range of drug development services over the next 10 years and to purchase Lilly's 450-acre early drug development campus in Greenfield, Indiana.

Effective immediately, Covance will assume control of the Greenfield campus and 264 Lilly employees will be working for Covance.